HBV-ISS (Dynavax).
Lists
Only you see this
Abstract
Dynavax is developing HBV-ISS (Heplisav), a vaccine based on hepatitis B virus (HB V) antigens and Dynavax' s immunostimulatory DNA sequence (ISS) ISS-1018, an adjuvant that acts as a TLR-9 agonist, for the potential prevention and treatment of HBV infection.
BibTeX
@inproceedings{sung2006hbv,
author = {Joseph J.�Y. Sung and Henry Lik-Yuen},
title = {{HBV-ISS (Dynavax).}},
booktitle = {PubMed},
year = {2006},
}Loading related content...